GRANULESNSEGranules India Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 6 Feb, 2026 · 14:46 IST

Granules India: Preferential issue update after shareholder approval

GRANULES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.2%Reaction day
₹578.80
prior close
₹559.50
announcement price
In-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.3%-1.8% vs market
Pharmaceuticals peers, median of 159sector-0.6%-1.6% vs sector

On the reaction day the stock moved 1.8 pts less than Nifty Smallcap 250 and 1.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
+0.1
15m
+0.1
30m
+0.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.2-0.3-1.8-0.6-1.6
Next day
-1.7+2.2-3.9+1.2-2.9
2d
-0.1+2.7-2.8+1.8-1.9
3d
+0.0+2.8-2.8+1.3-1.3
4d
-1.5+2.1-3.6+0.7-2.2
5d
-3.3+0.4-3.7+0.0-3.3
1w
-1.8+1.1-2.9-0.2-1.6
15d
+0.3-0.2+0.6-2.7+3.1
1m
-0.1-3.1+3.0-4.6+4.4
2m
+11.6-6.5+18.1-7.4+19.0
3m
+27.2+8.3+18.9+2.6+24.6
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Granules India shared details of its preferential issue approved by shareholders on January 22, 2026. The approval covers up to 2.5 crore warrants convertible to equity shares and up to 51,28,205 equity shares on a preferential basis. The company will recompute prices per SEBI ICDR rules where needed. Pending net proceeds will be parked in debt mutual funds, bank deposits, or government securities.

Likely market impact

Preferential allotment is progressing. Up to around 3 crore equity shares plus warrants may dilute existing shareholders. Proceeds parked safely until deployed.